JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M000119200 on March 21, 2000

J. Biol. Chem., Vol. 275, Issue 22, 17173-17179, June 2, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/22/17173    most recent
M000119200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schumacher, C.
Right arrow Articles by Wagner, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schumacher, C.
Right arrow Articles by Wagner, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The SCAN Domain Mediates Selective Oligomerization*

Christoph SchumacherDagger §, Hubert Wang||, Christian HonerDagger ||, Wei Ding, James KoehnDagger , Quentin Lawrence, Christopher M. CoulisDagger , Lei Lei Wang, Dennis Ballinger, Benjamin R. BowenDagger , and Susanne Wagner§

From the Dagger  Novartis Institute for Biomedical Research, Summit, New Jersey 07901 and  Myriad Genetics, Salt Lake City, Utah 84108

Received for publication, January 7, 2000, and in revised form, February 29, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The SCAN domain is described as a highly conserved, leucine-rich motif of approximately 60 amino acids found at the amino-terminal end of zinc finger transcription factors. Although no specific biological function has been attributed to the SCAN domain, its predicted amphipathic secondary structure led to the suggestion that this domain may mediate protein-protein associations. A yeast two-hybrid screen identified members of two SCAN domain protein families that interact with the SCAN domain of the zinc finger protein ZNF202. The interacting ZNF191 protein represents the family of SCAN domain-containing zinc finger proteins, whereas the novel SDP1 protein establishes a new family of genes that encode an isolated SCAN domain. Isolated SCAN domain proteins may form asymmetric homodimers in solution. Biochemical binding studies confirmed the associations of ZNF191 and SDP1 with ZNF202 and established the SCAN domain as a selective hetero- and homotypic oligomerization domain. SCAN mediated protein associations might therefore represent a new regulatory mechanism of transcriptional activity.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The SCAN or leucine-rich domain, originally identified by its homology with similar elements in several zinc finger transcription factors, consists of approximately 60 amino acids and is rich in leucine and glutamic acid residues (1). Most SCAN domain sequences are linked to Cys2-His2 zinc finger motifs through their carboxyl-terminal end. Although the function of the SCAN domain has not yet been elucidated, the predicted amphipathic structure of the domain led to the suggestion that SCAN box elements have the capacity to interact with other proteins, in particular with components of the transcriptional machinery (1).

The zinc finger protein ZNF2021 is expressed in two common splice variants, here referred to as m1 and m3 (2). Whereas the m1-splice form encodes a full-length protein of 648 amino acids with a SCAN box, a KRAB repression domain, and eight Cys2-His2 zinc finger motifs, the 133 amino acid product of the m3-splice form encompasses only the SCAN domain.2 These splice forms are conserved in the murine ZNF202 homolog, suggesting that the SCAN motif itself is an independent functional domain.3 The existence of other genes that encode SCAN elements as an isolated structural feature is further demonstrated by the recent identification of the murine Leap1/PCG-2 gene (GenBankTM accession AF106473) (3).

In order to study the function of the SCAN domain, we performed an extensive yeast two-hybrid screen for the identification of SCAN binding proteins. The screen, supported by biochemical association studies, suggested that SCAN motifs have the ability to associate selectively with each other. Furthermore, the first human gene encoding an isolated SCAN domain was identified. The formation of SCAN domain-mediated protein complexes may therefore modulate the biological function of transcription factors.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Two-hybrid Screen-- A Gal4-DNA binding domain (Gal4-DBD) fusion construct was generated by ligating a cDNA fragment of ZNF202 (amino acids 1-199) encompassing the SCAN domain into the Gal4p DNA-binding domain vector pGBT-C (bait Z1) (4). Additional Gal4-DBD fusion constructs contained the SCAN domain of SDP1, amino acids 1-179, or ZNF191, amino acids 1-204. The Gal4-DBD constructs ("baits") were transformed into the mating type yeast strain J692. Gal4 activation domain (Gal4-AD) libraries ("prey") from human B-cell, liver, kidney, and brain cDNA were obtained from CLONTECH and transformed into the alpha -mating type yeast strain J693. Individual Gal4-AD fusion constructs of ZNF202 encoded amino acids 1-44 (Z6), 1-171 (Z7), 202-328 (Z8), and 235-278 (Z10). Yeast strains containing the bait plasmid and the activation domain library were mated on filters and plated on minimal media lacking tryptophan, leucine, and histidine but containing 25 mM 3-amino-1,2-triazole. After incubation for approximately 8 days at 30 °C, the colonies that grew on the triple dropout media were subjected to a beta -galactosidase assay (5). Positive cDNA clones were sequenced and analyzed for homologies using the BLAST program (6).

SDP1 cDNA Analysis-- A full-length cDNA for SDP1 was obtained by rapid amplification of cDNA ends experiments from Marathon cDNA libraries (CLONTECH). The cDNAs were sequenced on both strands by fluorescent-labeled dye primer sequencing on ABI 377 sequencers (Applied Biosystems, Inc.). The assembled sequence was confirmed by sequencing a representative EST cDNA (GenBankTM accession number N75095; IMAGE Consortium cDNA clone 284448 obtained from Genome Systems).

Northern Blot Analysis-- Labeled SDP1 probes were synthesized in vitro in the presence of [alpha -32P]dCTP (Amersham Pharmacia Biotech) from a cDNA template encompassing the open reading frame using random primers and Klenow enzyme (Promega) and were used to probe multiple human tissue Northern blots (CLONTECH). Hybridization analysis was carried out in Quickhyb solution (Stratagene) at 65 °C and visualized by autoradiography. The blots were then stripped of radioactivity and reprobed with a 32P random prime-labeled glycerol-3-phosphate dehydrogenase cDNA probe (CLONTECH) to confirm equal loading.

GST Fusion Proteins-- The cDNA fragments encoding amino acids 1-199 (Z1) and 177-329 of the ZNF202-m1 open reading frame were subcloned directionally into the pGEX-4T bacterial expression vector (Amersham Pharmacia Biotech). A BamHI-EcoRI fragment of the ZNF191 cDNA which includes the SCAN domain was subcloned into pGEX1. The entire open reading frame of the SDP1 cDNA was subcloned directionally into pGEX-4T. All constructs were sequenced through the junctions to verify sequence fidelity and orientation. Expression and purification of the GST fusion proteins was done as described (7). Purity and integrity of the fusion proteins was assessed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie Blue staining (8). 35S-Labeling of GST-ZNF202[SCAN] was performed as detailed (9). Briefly, 200 ml of fresh LB medium with ampicillin (100 µg/ml) is inoculated with an overnight bacterial culture and grown for 3 h at 37 °C. The bacterial cell pellet was resuspended in 50 ml of prewarmed Dulbecco's modified Eagle's medium (Life Technologies, Inc.) with 2 mM glutamate and ampicillin (100 µg/ml) but lacking cysteine and methionine and was induced with 0.2 mM isopropyl-beta -D-thiogalactopyranoside (Sigma) for 10 min. Tran35S-label (ICN) was then added (5 mCi), and the incubation was continued for 2 h. The purification and elution was according to the standard procedure, and the eluted proteins were dialyzed overnight against 10 mM Tris-HCl, pH 7.5. The GST fusion protein was thrombin-cleaved according to the procedure of Smith (10). Briefly, bead-coupled fusion protein was resuspended in cleavage buffer containing 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2.5 mM CaCl2 and treated with 0.1% w/w thrombin (Sigma) at room temperature for 1 h. After centrifugation to extract the beads, the supernatant was analyzed by SDS-PAGE.

Antibodies-- The ZNF202 antiserum was generated by immunizing rabbits with the GST-ZNF202[KRAB] protein fragment that encompasses amino acids 177-329 of the ZNF202-m1 open reading frame. Antigen-specific antibodies were isolated from the polyclonal antiserum by immunoaffinity purification using an UltraLinkTM immobilization column (Pierce). Anti-XpressTM epitope mouse monoclonal antibodies were obtained from Invitrogen.

Transient Cell Transfections and Immunoprecipitations-- A polymerase chain reaction amplicon of the ZNF202-m1 open reading frame was subcloned into the expression vector pBIND (Promega) to afford pGal4-ZNF202-m1. The SDP1 open reading frame was directionally subcloned into the pcDNA3.1/His vector (Invitrogen) which encodes an amino-terminal Xpress epitopeTM. HEK 293 cells (2.5 million in a 100-mm dish) were transfected with expression plasmids using LipofectAMINE Plus (Life Technologies, Inc.) per manufacturer's recommendations. Control plates were transfected with green fluorescent protein and were inspected by fluorescent microscopy after 24 h to confirm >40% transfection efficiency. After 48 h, cells were removed from the plates, were pelleted by centrifugation, and then were lysed in 0.25 ml of lysis buffer that contained 1.0% Triton X-100 in Tris-HCl-buffered saline in the presence of sodium azide and a protease inhibitor mixture (Roche Molecular Biochemicals).

For each precipitation, 50 µl of cell lysate was mixed with 1 µg of monoclonal antibody against the Xpress tag (Invitrogen) or 2 µl of affinity purified anti-ZNF202 KRAB domain antibody in a total volume of 0.25 ml of binding buffer (0.1% Triton X-100 in Tris-buffered saline with sodium azide). Immune complexes were permitted to form for 2 h at 4 °C on an orbital mixer. Protein-A Sepharose slurry (40 µl, Amersham Pharmacia Biotech) was added and rocked for an additional hour. The beads were pelleted by centrifugation; the supernatant was removed, and the pelleted beads were washed three times with 1 ml of binding buffer. The beads were finally mixed with 40 µl of reducing loading buffer and heated prior to SDS-PAGE on 4-12% gradient gels. Reference samples (10 µl) of the lysates were loaded on each gel to confirm expression of the constructs and to permit an estimation of precipitation efficiency. Immunoblotting was performed under standard conditions using enhanced chemiluminescence detection (Amersham Pharmacia Biotech).

Far Western Blot-- GST fusion proteins were separated by SDS-PAGE and transferred onto nitrocellulose membranes (Immobilon). Immobilized proteins were renatured overnight in binding buffer. Binding buffer contained 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.1% (v/v) Tween 20, 2% (w/v) bovine serum albumin, 1 mM dithiothreitol, and 0.02% (w/v) sodium azide. After renaturation, the membranes were probed with either 35S-labeled GST-ZNF202[SCAN] or GST-cleaved ZNF202[SCAN] protein at 2 µg/ml binding buffer for 6 h. After washing the membrane in binding buffer three times, bound GST fusion protein was detected by autoradiography.

Gel Filtration Chromatography, Sedimentation Equilibrium Analysis, and Chemical Cross-linking of the ZNF202-m3 Protein-- A cDNA amplicon encoding the ZNF202-m3 splice form was subcloned into the NdeI-cloning site of the pET11a expression vector (Novagen). The expressed SCAN protein of 133 amino acids was purified over a cation exchange column using a POROS HS20 column (Perkin-Elmer) and analyzed by fast protein liquid chromatography. The analytical size exclusion chromatography was performed on a Superdex-75 HR 10/30 column (Amersham Pharmacia Biotech) equilibrated with a buffer containing 50 mM HEPES, pH 7.5, 100 mM KCl, and 2 mM dithiothreitol. A purified protein sample of approximately 1.0 mg in 100 µl of column equilibration buffer was loaded on the column and was eluted at a flow rate of 0.5 ml/min at 4 °C. Fractions of 0.5 ml were analyzed by absorbance at 280 nm and by the Bradford method for protein detection (Bio-Rad). The column was calibrated with bovine serum albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen (25 kDa), and ribonuclease A (13.7 kDa) as protein standards (Amersham Pharmacia Biotech).

For the postcentrifugation measurement of sedimentation equilibrium, 1.0 mg of purified protein sample was layered on top of a 5-20% linear sucrose gradient established in equilibration buffer. As molecular weight standards, aldolase (154 kDa) and ovalbumin (43 kDa) were analyzed onto a second gradient, whereas bovine serum albumin (67 kDa) was eluted onto a third gradient. Centrifugation was carried out in a Beckman SW40 rotor at 39,000 rpm for 23 h at 4 °C. Fractions of 0.4 ml were collected from the bottom to the top of the gradient, and the presence of protein was analyzed by the Bradford method.

For chemical cross-linking experiments, a purified ZNF202-m3 sample of 1.6 mg/ml (0.1 mM protein) concentration was incubated with 0.4 or 2 mM bis(sulfosuccinimidyl)suberate (Pierce) for 30 min at room temperature. The cross-linking reaction was subsequently quenched with 100 mM Tris-HCl, pH 7.5, and analyzed by denaturing SDS-PAGE followed by Coomassie Blue staining. A recombinant HtrA protease (a dodecamer in solution) and bovine serum albumin (a monomer) were used as cross-linking control samples in parallel reactions (11).

In Vitro Expression of SCAN Domain Proteins-- DNAs encoding the m1- and m3-splice form of ZNF202, SDP1, ZNF191 along with two SCAN domain encoding cDNA clones (mLD5-1, the murine homologue of LD5-1 or ZNF192: GenBankTM accession number NM006298; Zfp110, the murine neurothrophin receptor interacting factor: GenBankTM accession number MMU242914; mFPM315, the murine homologue of FMP315: GenBankTM accession number O14978) were directionally subcloned into the mammalian expression vector pcDNA3.1(-) (Invitrogen) or pBluescript II SK(+) (Stratagene). The cDNA templates were subsequently expressed in vitro in rabbit reticulocyte lysates in the presence of [35S]methionine using the TNT T7 Quick Transcription/Translation System (Promega) according to the manufacturer's procedure.

Affinity Purification of SCAN Domain Proteins-- GST fusion proteins (1.0 µg) were incubated overnight at 4 °C with 2.0 µl of rabbit reticulocyte lysate sample expressing a SCAN domain encoding cDNA template supplemented with HNTG buffer to a final volume of 200 µl. HNTG buffer contained 20 mM HEPES, pH 7.4, 150 mM NaCl, 0.1% Triton X-100, and 10% glycerol. 15 µl of glutathione-Sepharose beads (Amersham Pharmacia Biotech) were subsequently added for 40 min to collect the protein complexes. All samples were washed three times with ice-cold HNTG buffer, boiled in electrophoresis buffer, and analyzed by SDS-PAGE and autoradiography using an autoradiographic image enhancer (National Diagnostics).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A Yeast Two-hybrid Screen Identifies Interacting SCAN Domain Proteins-- A yeast two-hybrid approach was used to search for proteins that interact with the SCAN domain in vivo. The amino-terminal end of ZNF202 (amino acids 1-199) was fused in frame to the DNA binding domain of Gal4 and was used as bait (Z1) to screen independently brain, kidney, liver and B-cell Gal4 activation domain libraries (Fig. 1A). The screen resulted in the isolation of 48 interacting cDNA clones, 42 of which encoded a SCAN homology domain (Fig. 1B). Five cDNA clones corresponded to ZNF191, 28 to SDP1 (SCAN domain protein 1), 4 to SDP2, and 5 to SDP3. Whereas ZNF191 encodes a SCAN domain-containing zinc finger protein, the novel SDP1 cDNA of 0.9 kilobases was found to encode an isolated SCAN box without adjacent zinc finger motifs. The presence or absence of zinc finger motifs in SDP2 and SDP3 is unknown since the respective cDNAs are incomplete.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1.   The yeast two-hybrid screen for ZNF202 SCAN domain interacting proteins. A, schematic representation of ZNF202. Conserved domains are indicated by shaded boxes. Z1 represents the SCAN domain-encoding fragment of ZNF202 that was linked to the DNA binding domain of Gal4, whereas Z6, Z7, Z8, and Z10 indicate SCAN or KRAB domain-encompassing fragments linked to the Gal4 activation domain. Indicated are the respective amino acid residues of the ZNF202 constructs and its two splice forms, m1 and m3. B, interacting clones identified by screening activation domain libraries derived form brain, kidney, liver and B-cell tissue with Z1 and SDP1 bait proteins. The isolated sequences that corresponded to ZNF191, to four SCAN domain encoding novel cDNAs (SDP1-4), or to unrelated cDNAs (others) are indicated. C, Gal4 DNA-binding domain-linked fragments of ZNF202, SDP1, and ZNF191 were tested for their abilities to interact with activation domain-linked fragments of ZNF202. Occurrence (+) or absence (-) of growth is indicated.

An additional yeast two-hybrid screen was performed with a SDP1 bait and a kidney library that resulted in the isolation of five SCAN domain encoding cDNA clones (Fig. 1B). One cDNA clone corresponded to SDP1, indicating self-association, three clones represented SDP2, and one cDNA clone was identical to GenBankTM EST N29000 encoding SDP4. All individual interactions were subsequently confirmed by domain swap experiments (data not shown).

In order to further define the ZNF202 binding domain, additional ZNF202 Gal4 activation domain fusion constructs were directly probed with SCAN domains derived from ZNF202 (Z1), ZNF191, or SDP1 (Fig. 1A). The directed yeast mating reactions demonstrated that amino acids 1-171 of ZNF202 (Z7), in contrast to 1-44 (Z6), were sufficient for the interaction (Fig. 1C). The directed mating reactions indicated also the ability of ZNF202 to self-associate. In comparison, two KRAB domain-encompassing baits of ZNF202 (Z8 and Z10) did not interact confirming a sequence-specific association between these SCAN domain proteins.

The yeast two-hybrid screen suggested associations between SCAN domain proteins with two distinct motif features. ZNF191 or ZNF202 represent SCAN domain-containing zinc finger proteins, whereas SDP1 is characterized, similar to the m3-splice form of ZNF202, by an isolated SCAN domain. Tissue mRNA analysis showed that the SDP1 is ubiquitously highly expressed (Fig. 2A). The homology between the SCAN domains in SDP1, ZNF191, and ZNF202 is high with 47% identical residues over an alignment of 60 amino acids (Fig. 2B). Furthermore, the SCAN domains align with the conserved sequence residues published by Castillo et al. (3).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   SDP1 mRNA expression profile and SCAN domain alignment. A, radiolabeled cDNA probe for SDP1 was hybridized to tissue mRNA blots and detected by autoradiography. Molecular size markers are indicated on the left in kilobase units. The blot was subsequently hybridized to a glycerol-3-phosphate dehydrogenase probe to confirm equal RNA loading. Skel mus, skeletal muscle; PBL, peripheral blood leukocyte; Small Int, small intestine. B, alignment of the SCAN domain amino acid sequences of SDP1, ZNF191, and ZNF202. Identical residues are boxed. Residues that are conserved in the published consensus (Cons.) sequence are indicated in bold (3).

Hetero- and Homotypic Binding Ability of ZNF202-- In order to confirm the binding interactions of ZNF202 with ZNF191 and SDP1, we generated GST fusion proteins encompassing the ZNF202 KRAB domain or the respective SCAN boxes of these proteins. In an affinity purification study, we tested the ability of GST-ZNF202 fusion fragments to extract in vitro radiosynthesized SDP1 or ZNF191 protein from reticulocyte lysate preparations (Fig. 3, A and B). The SDS-PAGE showed that the GST-ZNF202[SCAN] protein construct, in contrast to the GST-ZNF202[KRAB] or the GST tag itself, precipitated the radiolabeled SDP1 or ZNF191 protein. The ability of ZNF202 to self-associate as detected in the yeast two-hybrid screen was further validated by affinity purification studies and far Western blotting (Fig. 3, C and D). The affinity purification study confirmed the ability of the GST-ZNF202[SCAN] protein construct to precipitate radiolabeled ZNF202-m3 protein from cell lysates (Fig. 3C). In a far Western blot approach, GST-linked ZNF202 protein fragments were probed with an [35S]methionine/cysteine metabolically labeled GST-ZNF202[SCAN] protein (Fig. 3D). The radiolabeled probe associated specifically with its unlabeled counterpart. The GST protein tag was not responsible for the observed protein complex formation. Likewise, far Western membranes of SCAN domain-encompassing GST fusion proteins probed with a radiolabeled GST-ZNF202[SCAN] fusion protein demonstrated binding of ZNF202 to SDP1, ZNF191, or ZNF202 itself (Fig. 3E). In order to test the possibility that the observed associations were facilitated by the GST protein tag, a GST-cleaved radiolabeled ZNF202[SCAN] protein was shown to maintain the association with the SDP1 fusion protein (Fig. 3F).


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 3.   Hetero- and homotypic binding of ZNF202 detected by affinity precipitation and far Western blotting. For affinity precipitations, rabbit reticulocyte lysate samples expressing radiolabeled SDP1 (A), ZNF191 (B), or ZNF202-m3 (C) were extracted with the indicated GST fusion proteins of ZNF202. The precipitations were subsequently analyzed by SDS-PAGE and autoradiography. For far Western blotting, GST fusion proteins as indicated at the top of the panels were subjected to SDS-PAGE and transferred onto membranes. The membranes were probed with a radiolabeled GST-Z1 protein construct of ZNF202 (D and E) or with a radiolabeled GST-cleaved Z1 fragment of ZNF202 (F). Molecular size markers are indicated in kilodalton units.

Because we could demonstrate association between SCAN domain-containing proteins in several experimental systems in vitro, we next sought to determine whether SCAN domain-containing proteins interact in a cellular milieu. Various expression constructs of ZNF202 and SDP1 with epitope tags were employed in co-immunoprecipitation/immunoblot experiments in order to demonstrate intracellular associations. Fig. 4A shows an anti-ZNF202[KRAB] immunoblot of lysates from cells transfected with pGal4-ZNF202-m1 alone or with pGal4-ZNF202-m1 plus pXpress-SDP1. Lysates from these cells contain an appropriately sized (~110 kDa) immunoreactive band (3rd and 4th lanes). The anti-Xpress immunoprecipitation of the pGal4-ZNF202-m1/pXpress-SDP1 cotransfection shows a robust band (2nd lane), indicative of intracellular association between ZNF202 and SDP1, whereas a control antibody yielded no band (1st lane). Fig. 4B represents the reciprocal of Fig. 4A. Instead of coprecipitating ZNF202 with antibodies to tagged forms of SDP1, Xpress-SDP1 was precipitated with anti-ZNF202[KRAB] antibody (2nd lane). Thus, in lysates from appropriately transfected cells, ZNF202 precipitates SDP1 and SDP1 precipitates ZNF202 precisely as was seen in affinity purification studies and in far Western experiments.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Association of ZNF202 and SDP1 in transfected HEK 293 cells. HEK 293 cells were transiently transfected with expression plasmids for Gal4-ZNF202-m1 or Xpress epitope-tagged SDP1 as indicated below the panels. The cell lysates were subjected to immunoprecipitations and SDS-PAGE analysis as indicated above the panels. The Western blots were probed with antibodies against the ZNF202 KRAB domain (A) or the Xpress epitope (B). The molecular size markers show the detection of Gal4-ZNF202-m1 (110 kDa) or Xpress-SDP1 (30 kDa).

The ZNF202-m3 Protein Forms an Asymmetric Homodimer-- In order to determine the stoichiometry of the ZNF202 SCAN protein complex in solution, a bacterially expressed ZNF202-m3 protein was purified over a cation exchange column and subjected to size exclusion chromatography. A fast protein liquid chromatography experiment using a prepacked Superdex-75 HR column eluted the SCAN protein in a 52-kDa molecular size fraction as calculated by plotting the logarithm of the molecular mass of the protein standards against the elution volume (Fig. 5A). In contrast, an SDS-PAGE analysis of this protein separated the denatured and thus monomeric form at 15-kDa molecular size as detected by Coomassie Blue gel staining (Fig. 5A, inset). In addition, the postcentrifugation sedimentation equilibrium of the ZNF202-m3 protein through a 5-20% sucrose gradient was analyzed. As shown in Fig. 5B, the sedimentation profile of the m3 protein showed a well defined peak at approximately 48 kDa in the presence of 100 mM KCl. Thus, the migratory properties of the ZNF202-m3 protein subjected to size exclusion chromatography and sedimentation analysis suggest that the SCAN domain of ZNF202 forms either a trimeric complex or a modestly asymmetric dimer in a native environment. Chemical cross-linking experiments, however, did not reveal a trimeric complex but rather a dimeric species (Fig. 5C). Thus, the combination of gel filtration, sedimentation equilibrium, and cross-linking experiments of the ZNF202-m3 protein support the presence of an asymmetric dimeric protein.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   Determination of the oligomeric state of the ZNF202-m3 protein in solution. A, the size exclusion chromatogram was plotted as the absorbance, A280 nm, of individual fraction samples versus the elution volume from a Superdex-75 HR column in ml units. The elution profile for the protein standards in kDa units and the void volume, V0, is indicated at the top of the panel. The ZNF202-m3 protein, as shown by a solid line, was eluted as a single species with an estimated molecular mass of 52 kDa. B, the postcentrifugation measurement of the ZNF202-m3 sedimentation equilibrium profile through a 5-20% sucrose gradient in presence of 100 mM KCl was established by collecting fractions from the bottom to the top of the gradient and determining the protein concentrations by the Bradford method. The elution profiles of molecular mass standards indicated in kDa are shown as dotted lines. C, a representative chemical cross-linking reaction of ZNF202-m3 with bis(sulfosuccinimidyl)suberate (BS3) in various molar ratios as indicated on top of the panel was resolved by SDS-PAGE and Coomassie staining. Molecular weight markers are indicated in kDa units.

Selective SCAN Domain Association Abilities of ZNF202, SDP1, and ZNF191-- In a preliminary attempt to evaluate the selectivity of the SCAN domain-mediated protein associations, we transcribed and translated in vitro cDNA templates for ZNF202-m1, ZNF191, SDP1, and three unrelated SCAN domain-containing zinc finger proteins indicated as mLD5-1, Zfp110, and mFPM315. The cell lysates were incubated with GST-fused SCAN box sequences derived from ZNF202, SDP1, or ZNF191, and the recaptured fusion proteins were analyzed for binding in vitro produced radiolabeled protein (Fig. 6). All three GST fusion proteins associated strongly with radiolabeled SDP1. Conversely, the GST-SDP1 construct readily precipitated ZNF202, SDP1 itself, ZNF191, mLD5-1, and Zfp110. Therefore, the SCAN domain encoded by SDP1 revealed the highest association affinity that was also observed in the far Western experiment (Fig. 3C). Furthermore, SDP1 showed the ability to self-associate. which confirmed the interaction detected in the yeast two-hybrid screen. The fusion proteins of ZNF202 and ZNF191 revealed similar affinities for the radiolabeled proteins yet differed in their affinity for mLD5-1 and Zfp110. Whereas the ZNF202 fusion protein interacted weakly with mLD5-1, the ZNF191 fusion protein precipitated Zfp110. In comparison, the GST-SDP1 construct bound both mLD5-1 and Zfp110. None of the fusion proteins interacted with mFPM315. Therefore, the individual affinity of the fusion proteins to the unrelated SCAN proteins suggests the ability of SCAN domains to associate selectively with each other.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 6.   Selectivity of SCAN domain-mediated dimerizations detected by affinity precipitation. SCAN domain-encoding cDNAs as indicated at the left side were transcribed and translated in rabbit reticulocyte lysates (RRCL) in the presence of [35S]methionine. Protein expression is demonstrated in the panels at the right side. GST fusion proteins as indicated at the top were used to affinity purify the radiolabeled proteins. Precipitates were analyzed by SDS-PAGE and autoradiography. Molecular size markers are indicated on the right in kilodalton units.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The SCAN domain is a sequence motif of unknown function that is common to zinc finger proteins. We provide evidence that the SCAN domain mediates selective protein oligomerization. A yeast two-hybrid screen identified homotypic and heterotypic interactions between SCAN domain-containing proteins. Biochemical binding experiments confirmed the interactions in vitro as well as in vivo and revealed selectivity in the SCAN domain-mediated protein associations as individual SCAN domains exhibited distinct differences in their ability to bind to other SCAN domain proteins. The structural components within a SCAN domain protein that contribute to binding selectivity and affinity remain to be elucidated. Sequence alignments of SCAN domains show a high degree of amino acid conservation that suggests that relatively few amino acids contribute to binding specificity (3). A hydrodynamic analysis of the ZNF202-m3 protein by gel filtration chromatography and postcentrifugation measurement of sedimentation equilibrium suggests the formation of a trimeric or asymmetric dimeric protein complex in solution. Dynamic light scattering investigations of the ZNF202-m3 protein in solution could not distinguish between these two oligomerization states.4 In vitro chemical cross-linking experiments, however, indicated a dimeric protein in identical buffer conditions. Therefore, we presume the ZNF202-m3 protein to form an asymmetric dimer in solution.

The state of oligomerization in SCAN domain-mediated homo- or heterotypic protein associations may share similarities with the BTB/POZ domain-containing proteins (12, 13). The GAGA protein has been shown to form BTB/POZ domain-mediated dimers, tetramers, and oligomers in vitro, whereas the BTB/POZ domain from the promyelocytic leukemia zinc finger oncoprotein crystallized in a tightly intertwined dimer (14, 15). Furthermore, the BTB/POZ domain formed dimer-dimer interactions in the crystals that suggested a mode of higher order protein oligomerization (16).

Transcription factors are composed of functional domains that contribute to DNA binding, ligand binding, and transcriptional activation or repression (17, 18). One important regulatory mechanism affecting both DNA binding affinity as well as transcriptional activation is oligomerization (19, 20). Whereas zinc finger transcription factors of the Cys2-His2 class are reported to bind DNA in monomeric form, SCAN domain-mediated association with other zinc finger proteins may modulate their biological function (21-23). The juxtaposition of zinc finger motifs through protein oligomerization may lead to altered DNA binding activities. For example, the self-oligomerization of the amino-terminal BTB/POZ domain of the GAGA zinc finger protein resulted in increased DNA binding affinity and transcriptional activity (14, 24). Recently, BTB/POZ domain-mediated oligomerization of transcription factors has been suggested to serve as combinatorial codes for gene expression (25).

The identification of the SDP1 protein establishes a new family of proteins characterized by an isolated SCAN domain. The amino acid sequence conservation between SDP1 and PGC-2 is high, and consequently SDP1 may represent the human ortholog of the murine PGC-2 protein (3). A third protein that contains only a SCAN domain is encoded by the m3-splice form of ZNF202.

Single domain proteins that function as intermolecular regulators of transcription have been described previously. The PGC-2 protein was shown to interact with the nuclear receptor peroxosome proliferator-actived receptor gamma . Upon association, PGC-2 increases the transcriptional activity of peroxosome proliferator-actived receptor gamma  in the absence of any intrinsic transcriptional activity of PGC-2 (3). The biological effect of peroxosome proliferator-actived receptor gamma  may be modulated through competitive binding of PGC-2 and other transcriptional cofactors. Conversely, the DNA binding activities of some basic helix-loop-helix motif-containing transcription factors were shown to be inhibited by Id proteins. The Id family of helix-loop-helix proteins, which lacks a basic DNA-binding domain, functions as a negative regulator of basic helix-loop-helix proteins through the formation of inactive heterodimers with intact basic helix-loop-helix transcription factors (26, 27). Similarly, isolated SCAN domain proteins such as SDP1 or ZNF202-m3 may modulate the formation of functional SCAN domain zinc finger transcription factors.

The elucidation of the biological consequences arising from associations between SCAN domain proteins may offer new insights into the regulation of zinc finger transcription factors. Transient transfection experiments with appropriate reporter gene constructs may address the impact of SCAN domain-mediated oligomerization on gene expression. Particularly, the association of two different splice forms, such as the m1 and m3 forms of ZNF202, may represent a novel biological mechanism to regulate transcriptional activity.

Note Added in Proof-- Following submission of this manuscript, Williams et al. (28) similarly reported that SCAN domain zinc finger proteins may form oligomeric associations.

    ACKNOWLEDGEMENTS

We thank Drs. Kenton Zavitz and Mathew Toth for critical reading of the manuscript.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) N75095, U68536, and AF204271.

§ To whom correspondence should be addressed: Novartis Institute for Biomedical Research, MCD Research, 556 Morris Ave., Summit, NJ 07901. Tel.: 908-277-4797; Fax: 908-277-4756; E-mail: christopher. schumacher@pharma.novartis.com.

|| Both authors contributed equally to this work.

Published, JBC Papers in Press, March 21,2000, DOI 10.1074/jbc.M000119200

2 S. Wagner, unpublished results.

3 S. Morham, L. Huwyler, and M. Toth, unpublished results.

4 K. Clark and T. Stams, unpublished results.

    ABBREVIATIONS

The abbreviations used are: ZNF, zinc finger protein; Gal, galactosidase; DBD, DNA binding domain; AD, activation domain; SDP, SCAN-domain protein; PAGE, polyacrylamide gel electrophoresis; GST, glutathione S-transferase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Williams, A. J., Khachigian, L. M., Shows, T., and Collins, T. (1995) J. Biol. Chem. 270, 22143-22152
2. Monaco, C., Helmer, Citterich, M., Caprini, E., Vorechovsky, I., Russo, G., Croce, C. M., Barbanti-Brodano, G., and Negrini, M. (1998) Genomics 52, 358-362
3. Castillo, G., Brun, R. P., Rosenfield, J. K., Hauser, S., Won Park, C., Troy, A. E., Wright, M. E., and Spiegelman, B. M. (1999) EMBO J. 18, 3676-3687
4. Bartel, P. L., Roecklein, J. A., SenGupta, D., and Fields, S. (1996) Nat. Genet. 12, 72-77
5. Breeden, L., and Nasmyth, K. (1985) Cold Spring Harbor Symp. Quant. Biol. 50, 643-650
6. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389-3402
7. Smith, D. B., and Johnson, K. S. (1988) Gene (Amst.) 67, 31-40
8. Laemmli, U. K. (1970) Nature 227, 680-685
9. Feller, S. M., Knudsen, B., Wong, T. W., and Hanafusa, H. (1995) Methods Enzymol. 255, 369-378
10. Smith, D. B. (1993) Methods Mol. Cell Biol. 4, 220-229
11. Kim, K. I., Park, S. C., Kang, S. H., Cheong, G. W., and Chung, C. H. (1999) J. Mol. Biol. 294, 1363-1374
12. Bardwell, V. J., and Treisman, R (1994) Genes Dev. 8, 1664-1677
13. Albagli, O., Dhordain, P., Deweindt, C., Lecocq, G., and Leprince, D. (1995) Cell Growth Differ. 6, 1193-1198
14. Espinas, M. L., Jimenez-Garcia, E., Vaquero, A., Canudas, S., Bernues, J., and Azorin, F. (1999) J. Biol. Chem. 274, 16461-16469
15. Ahmad, K. F., Engel, C. K., and Privé, G. G. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12123-12128
16. Li, X., Peng, H., Schultz, D. C., Lopez-Guisa, J. M., Rauscher, F. J., III, and Marmorstein, R. (1999) Cancer Res. 59, 5275-5282
17. Lefstin, J. A., and Yamamoto, K. R. (1998) Nature 392, 885-888
18. Tan, S., and Richmond, T. J. (1998) Curr. Opin. Struct. Biol. 8, 41-48
19. Chen, L. (1999) Curr. Opin. Struct. Biol. 9, 48-55
20. Wolberger, C. (1998) Curr. Opin. Genet. & Dev. 8, 552-559
21. Pavletich, N. P., and Pabo, C. O. (1991) Science 252, 809-817
22. Fairall, L., Schwabe, J. W., Chapman, L., Finch, J. T., and Rhodes, D. (1993) Nature 366, 483-487
23. Pavletich, N. P., and Pabo, C. O. (1993) Science 261, 1701-1707
24. Katsani, K. R., Hajibagheri, M. A., and Verrijzer, C. P. (1999) EMBO J. 18, 698-708
25. Kobayashi, A., Yamagiwa, H., Hoshino, H., Muto, A., Sato, K., Morita, M., Hayashi, N., Yamamoto, M., and Igarashi, K. (2000) Mol. Cell. Biol. 20, 1733-1746
26. Sun, X. H., Copeland, N. G., Jenkins, N. A., and Baltimore, D. (1991) Mol. Cell. Biol. 11, 5603-5611
27. Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L., and Weintraub, H. (1990) Cell 61, 49-59
28. Williams, A. J., Blacklow, S. C., and Collins, T. (1999) Mol. Cell. Biol. 19, 8526-8535


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
J. Harper, L. Yan, R. M. Loureiro, I. Wu, J. Fang, P. A. D'Amore, and M. A. Moses
Repression of Vascular Endothelial Growth Factor Expression by the Zinc Finger Transcription Factor ZNF24
Cancer Res., September 15, 2007; 67(18): 8736 - 8741.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. C. Stene, R. Frikke-Schmidt, B. G. Nordestgaard, and A. Tybjaerg-Hansen
Zinc Finger Protein 202, genetic variation, and HDL cholesterol in the general population
J. Lipid Res., May 1, 2006; 47(5): 944 - 952.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Tan, S. Kim, and T. G. Boyer
Tetrameric Oligomerization Mediates Transcriptional Repression by the BRCA1-dependent Kruppel-associated Box-Zinc Finger Protein ZBRK1
J. Biol. Chem., December 31, 2004; 279(53): 55153 - 55160.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
C. Looman, M. Abrink, C. Mark, and L. Hellman
KRAB Zinc Finger Proteins: An Analysis of the Molecular Mechanisms Governing Their Increase in Numbers and Complexity During Evolution
Mol. Biol. Evol., December 1, 2002; 19(12): 2118 - 2130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Stone, J. L. Maki, S. C. Blacklow, and T. Collins
The SCAN Domain of ZNF174 Is a Dimer
J. Biol. Chem., February 8, 2002; 277(7): 5448 - 5452.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
X.-P. Yang, L. A. Freeman, C. L. Knapper, M. J. A. Amar, A. Remaley, H. B. Brewer Jr., and S. Santamarina-Fojo
The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene
J. Lipid Res., February 1, 2002; 43(2): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Collins, J. R. Stone, and A. J. Williams
All in the Family: the BTB/POZ, KRAB, and SCAN Domains
Mol. Cell. Biol., June 1, 2001; 21(11): 3609 - 3615.
[Full Text]


Home page
J. Biol. Chem.Home page
M. Porsch-Ozcurumez, T. Langmann, S. Heimerl, H. Borsukova, W. E. Kaminski, W. Drobnik, C. Honer, C. Schumacher, and G. Schmitz
The Zinc Finger Protein 202 (ZNF202) Is a Transcriptional Repressor of ATP Binding Cassette Transporter A1 (ABCA1) and ABCG1 Gene Expression and a Modulator of Cellular Lipid Efflux
J. Biol. Chem., April 6, 2001; 276(15): 12427 - 12433.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/22/17173    most recent
M000119200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schumacher, C.
Right arrow Articles by Wagner, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schumacher, C.
Right arrow Articles by Wagner, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.